Brainstorm Cell Therapeutics Inc. (BCLI)

Operating Cash Flow (Statement)

-$4.06M

TTM · Period ending: · USD

BCLI logo

BCLI Operating Cash Flow (Statement)

Latest reported-$4.06M
BCLI Cash from Operations (-$7.44K → -$4.06M)
High-resolution chart · PNG

BCLI operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Brainstorm Cell Therapeutics Inc. Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-6,975,000
-9,093,000
-20,458,000
-19,320,000
-26,265,000
-35,193,000
-11,247,000
-12,388,000
-2,364,000
-5,858,000
-7,408,000
-4,487,000
-4,054,000
-2,916,000
-2,223,000
-2,069,000
-744,000
-1,734,000
-1,774,000
-855,000
-1,252,281
-677,836
-15,436
-7,012
-7,440
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.